Gruell, H, Gunst, J D, Cohen, Y Z, Pahus, M H, Malin, J J, Platten, M, Millard, K G, Tolstrup, M, Jones, R B, Conce Alberto, W D, Lorenzi, J C C, Oliveira, T Y, Kümmerle, T, Suárez, I, Unson-O'Brien, C, Nogueira, L, Olesen, R, Østergaard, L, Nielsen, H, Lehmann, C, Nussenzweig, M C, Fätkenheuer, G, Klein, F, Caskey, M & Søgaard, O S 2022, ' Effect of 3BNC117 and romidepsin on the HIV-1 reservoir in people taking suppressive antiretroviral therapy (ROADMAP) : a randomised, open-label, phase 2A trial ', The Lancet Microbe, vol. 3, no. 3, pp. e203-e214 . https://doi.org/10.1016/S2666-5247(21)00239-1 Gruell, H, Gunst, J D, Cohen, Y Z, Pahus, M H, Malin, J J, Platten, M, Millard, K G, Tolstrup, M, Jones, R B, Conce Alberto, W D, Lorenzi, J C C, Oliveira, T Y, Kümmerle, T, Suárez, I, Unson-O'Brien, C, Nogueira, L, Olesen, R, Østergaard, L, Nielsen, H, Lehmann, C, Nussenzweig, M C, Fätkenheuer, G, Klein, F, Caskey, M & Søgaard, O S 2022, ' Effect of 3BNC117 and romidepsin on the HIV-1 reservoir in people taking suppressive antiretroviral therapy (ROADMAP): a randomised, open-label, phase 2A trial ', The Lancet. Microbe, vol. 3, no. 3, pp. e203-e214 . https://doi.org/10.1016/S2666-5247(21)00239-1 Lancet Microbe